These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 8108191)

  • 1. Lipoprotein(a) serum levels and apolipoprotein(a) phenotypes in children with chronic renal disease.
    Querfeld U; Lang M; Friedrich JB; Kohl B; Fiehn W; Schärer K
    Pediatr Res; 1993 Dec; 34(6):772-6. PubMed ID: 8108191
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lipoprotein(a) in chronic renal disease.
    Stenvinkel P; Berglund L
    Miner Electrolyte Metab; 1996; 22(1-3):16-21. PubMed ID: 8676811
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apolipoprotein(a) phenotypes and lipoprotein(a) concentrations in patients with renal failure.
    Milionis HJ; Elisaf MS; Tselepis A; Bairaktari E; Karabina SA; Siamopoulos KC
    Am J Kidney Dis; 1999 Jun; 33(6):1100-6. PubMed ID: 10352198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein(a) and apolipoprotein(a) isoforms and proteinuria in patients with moderate renal failure.
    Sechi LA; Zingaro L; Catena C; Perin A; De Marchi S; Bartoli E
    Kidney Int; 1999 Sep; 56(3):1049-57. PubMed ID: 10469373
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Serum lipoprotein(a) concentrations and apolipoprotein(a) phenotypes in hemodialysis, chronic ambulatory peritoneal dialysis and post-transplant patients.
    Kimak E; Solski J
    Ren Fail; 2002 Mar; 24(2):187-95. PubMed ID: 12071592
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoprotein(a) in patients with the nephrotic syndrome: influence of immunosuppression and proteinuria.
    Wanner C; Bartens W; Nauck M; Zäuner I; Greiber S; Schollmeyer P
    Miner Electrolyte Metab; 1996; 22(1-3):26-30. PubMed ID: 8676820
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lipoprotein(a) in nephrotic syndrome and end-stage renal disease.
    Greiber S; Wanner C
    Miner Electrolyte Metab; 1997; 23(3-6):161-5. PubMed ID: 9387108
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Elevated plasma concentrations of lipoprotein(a) in patients with end-stage renal disease are not related to the size polymorphism of apolipoprotein(a).
    Dieplinger H; Lackner C; Kronenberg F; Sandholzer C; Lhotta K; Hoppichler F; Graf H; König P
    J Clin Invest; 1993 Feb; 91(2):397-401. PubMed ID: 8432847
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protein loss and genetic polymorphism of apolipoprotein(a) modulate serum lipoprotein(a) in CAPD patients.
    Wanner C; Bartens W; Walz G; Nauck M; Schollmeyer P
    Nephrol Dial Transplant; 1995; 10(1):75-81. PubMed ID: 7724034
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Alterations of Lp (a) lipoprotein in patients with chronic renal failure treated by continuous ambulatory peritoneal dialysis].
    Takegoshi T; Kitoh C; Shimada T; Kawai K; Yamazaki Y; Mabuchi H
    Nihon Jinzo Gakkai Shi; 1993 Jun; 35(6):757-63. PubMed ID: 8377289
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Elevated plasma lipoprotein(a) in patients with the nephrotic syndrome.
    Wanner C; Rader D; Bartens W; Krämer J; Brewer HB; Schollmeyer P; Wieland H
    Ann Intern Med; 1993 Aug; 119(4):263-9. PubMed ID: 8328733
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A study of clinical significance of Lp[a] lipoprotein in patients with chronic renal failure treated by hemodialysis].
    Takegoshi T; Kitoh C; Yamazaki Y
    Nihon Jinzo Gakkai Shi; 1990 Jun; 32(6):667-71. PubMed ID: 2145455
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Serum lipoprotein(a) concentration in patients with chronic renal failure receiving haemodialysis: influence of apolipoprotein (a) genetic polymorphism.
    Auguet T; Sentí M; Rubiés-Prat J; Pelegrí A; Pedro-Botet J; Nogués X; Romero R
    Nephrol Dial Transplant; 1993; 8(10):1099-103. PubMed ID: 8272223
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein(a)-associated atherothrombotic risk in hemodialysis patients.
    Emanuele E; Lusignani LS; Peros E; Montagna G; D'Angelo A; Montagna L; Geroldi D
    Am J Nephrol; 2004; 24(2):221-9. PubMed ID: 15017119
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Multicenter study of lipoprotein(a) and apolipoprotein(a) phenotypes in patients with end-stage renal disease treated by hemodialysis or continuous ambulatory peritoneal dialysis.
    Kronenberg F; König P; Neyer U; Auinger M; Pribasnig A; Lang U; Reitinger J; Pinter G; Utermann G; Dieplinger H
    J Am Soc Nephrol; 1995 Jul; 6(1):110-20. PubMed ID: 7579063
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Alterations of serum lipoprotein (a) levels in continuous ambulatory peritoneal dialysis (CAPD) patients].
    Tanaka S
    Nihon Jinzo Gakkai Shi; 1994 Jun; 36(6):746-51. PubMed ID: 8084076
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Lipoprotein (a) in children with chronic renal failure treated conservatively].
    Zwolińska D; Kiliś-Pstrusińska K; Szprynger K
    Pol Merkur Lekarski; 1997 Sep; 3(15):126-8. PubMed ID: 9461709
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of dialysis type on serum lipids, apolipoproteins, and lipoproteins.
    Kanbay M; Delibasi T; Kaya A; Aydogan T; Koca C; Akcay A; Duranay M; Yigitoglu R
    Ren Fail; 2006; 28(7):567-71. PubMed ID: 17050239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Lipoprotein (a) in children with end stage renal failure on maintenance hemodialysis and continuous ambulatory peritoneal dialysis].
    Zwolińska D; Szprynger K
    Przegl Lek; 1997; 54(5):320-3. PubMed ID: 9380806
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Analyses of serum lipoprotein(a) and the relation to phenotypes and genotypes of apolipoprotein(a) in type 2 diabetic patients with retinopathy.
    Suehiro M; Ohkubo K; Kato H; Kido Y; Anzai K; Oshima K; Ono J
    Exp Clin Endocrinol Diabetes; 2002 Oct; 110(7):319-24. PubMed ID: 12397529
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.